Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Cognex Corpのコンセンサス目標株価は$48.05で、20人のアナリストの評価に基づいて設定されています。最高値は$60で、11 6, 2023にRaymond Jamesが発表しました。最低値は$32で、6 16, 2025にBairdが発表しました。最後の3人のアナリスト評価は10 8, 2025、10 8, 2025、9 16, 2025にTruist Securities、Barclays、Goldman Sachsから発表されました。Truist Securities、Barclays、Goldman Sachsの間の平均目標株価は$46.67であり、これらの最後の3人のアナリスト評価からCognex Corpに対する暗黙の0.44% upsideが示されています。
1アナリスト評価から算出
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
10/08/2025 | -3.14% | Truist Securities | $37 → $45 | Maintains | Hold | |||
10/08/2025 | 18.38% | Barclays | → $55 | Initiates | → Overweight | |||
09/16/2025 | -13.9% | Goldman Sachs | $36 → $40 | Maintains | Sell | |||
09/15/2025 | -3.14% | JP Morgan | → $45 | Initiates | → Neutral | |||
08/04/2025 | -24.67% | DA Davidson | $32 → $35 | Maintains | Neutral | |||
08/01/2025 | 24.84% | UBS | $53 → $58 | Maintains | Buy | |||
08/01/2025 | 7.62% | Keybanc | → $50 | Upgrade | Sector Weight → Overweight | |||
07/31/2025 | -3.14% | Needham | $36 → $45 | Maintains | Buy | |||
07/14/2025 | -20.36% | Citigroup | $30 → $37 | Maintains | Neutral | |||
06/16/2025 | -31.12% | DA Davidson | $32 → $32 | Maintains | Neutral | |||
06/16/2025 | -31.12% | Baird | $30 → $32 | Maintains | Neutral | |||
06/12/2025 | -31.12% | Goldman Sachs | $29 → $32 | Maintains | Sell | |||
06/11/2025 | -22.51% | Needham | $33 → $36 | Maintains | Buy | |||
05/06/2025 | -37.58% | Goldman Sachs | $33 → $29 | Maintains | Sell | |||
05/05/2025 | -31.12% | DA Davidson | $35 → $32 | Maintains | Neutral | |||
05/02/2025 | -35.43% | Baird | $31 → $30 | Maintains | Neutral | |||
05/02/2025 | 14.08% | UBS | $56 → $53 | Maintains | Buy | |||
05/01/2025 | -28.97% | Needham | $41 → $33 | Maintains | Buy | |||
04/14/2025 | -44.04% | Citigroup | $37 → $26 | Maintains | Neutral | |||
04/08/2025 | -37.58% | Truist Securities | $37 → $29 | Maintains | Hold | |||
03/12/2025 | 18.38% | Stephens & Co. | $55 → $55 | Reiterates | Overweight → Overweight | |||
02/18/2025 | -24.67% | Goldman Sachs | $39 → $35 | Maintains | Sell | |||
02/18/2025 | 20.53% | UBS | $58 → $56 | Maintains | Buy | |||
02/18/2025 | -18.21% | Baird | $42 → $38 | Maintains | Neutral | |||
02/14/2025 | -20.36% | Truist Securities | $43 → $37 | Reiterates | Hold → Hold | |||
02/14/2025 | -11.75% | Needham | $47 → $41 | Maintains | Buy | |||
01/16/2025 | -7.45% | Truist Securities | $42 → $43 | Maintains | Hold | |||
01/13/2025 | -9.6% | Citigroup | $44 → $42 | Maintains | Neutral | |||
01/02/2025 | 18.38% | Stephens & Co. | $55 → $55 | Reiterates | Overweight → Overweight | |||
12/19/2024 | 5.47% | Cantor Fitzgerald | → $49 | Initiates | → Overweight | |||
12/19/2024 | -9.6% | Truist Securities | $43 → $42 | Maintains | Hold | |||
12/18/2024 | 24.84% | UBS | $57 → $58 | Maintains | Buy | |||
11/05/2024 | -7.45% | Truist Securities | $46 → $43 | Downgrade | Buy → Hold | |||
11/01/2024 | 1.16% | Needham | $50 → $47 | Maintains | Buy | |||
08/05/2024 | -16.06% | DA Davidson | $41 → $39 | Maintains | Neutral | |||
08/05/2024 | -3.14% | Stephens & Co. | $45 → $45 | Reiterates | Equal-Weight → Equal-Weight | |||
08/05/2024 | -9.6% | Baird | $46 → $42 | Maintains | Neutral | |||
08/02/2024 | -16.06% | Goldman Sachs | $45 → $39 | Maintains | Sell | |||
08/02/2024 | -0.99% | Truist Securities | $55 → $46 | Maintains | Buy | |||
08/02/2024 | 7.62% | Needham | $57 → $50 | Maintains | Buy | |||
07/29/2024 | 22.69% | Needham | $48 → $57 | Maintains | Buy | |||
07/23/2024 | 24.84% | Vertical Research | → $58 | Initiates | → Buy | |||
07/02/2024 | 18.38% | Truist Securities | $50 → $55 | Maintains | Buy | |||
05/07/2024 | 11.92% | HSBC | → $52 | Upgrade | Hold → Buy | |||
05/07/2024 | 7.62% | Truist Securities | $47 → $50 | Reiterates | Buy → Buy | |||
05/06/2024 | 22.69% | UBS | $54 → $57 | Maintains | Buy | |||
05/06/2024 | -11.75% | Goldman Sachs | $36 → $41 | Maintains | Sell | |||
05/03/2024 | -3.14% | Stephens & Co. | $40 → $45 | Maintains | Equal-Weight | |||
05/03/2024 | 18.38% | Bernstein | $52 → $55 | Maintains | Outperform | |||
05/03/2024 | 3.31% | Needham | $46 → $48 | Maintains | Buy | |||
05/03/2024 | -5.29% | Baird | $40 → $44 | Maintains | Neutral | |||
04/08/2024 | -7.45% | Citigroup | $41 → $43 | Maintains | Neutral | |||
03/19/2024 | 16.23% | UBS | $42 → $54 | Upgrade | Neutral → Buy | |||
03/14/2024 | 1.16% | Truist Securities | → $47 | Initiates | → Buy | |||
11/06/2023 | 29.14% | Raymond James | $65 → $60 | Maintains | Strong Buy | |||
11/02/2023 | -13.9% | Stephens & Co. | $55 → $40 | Maintains | Equal-Weight | |||
11/01/2023 | -0.99% | Needham | $55 → $46 | Maintains | Buy | |||
10/10/2023 | -13.9% | Goldman Sachs | $45 → $40 | Maintains | Sell | |||
10/03/2023 | — | Keybanc | — | Initiates | → Sector Weight | |||
09/01/2023 | 18.38% | Needham | → $55 | Reiterates | Buy → Buy | |||
08/30/2023 | 11.92% | Citigroup | → $52 | Initiates | → Neutral | |||
08/07/2023 | -0.99% | Credit Suisse | $47 → $46 | Maintains | Neutral | |||
08/04/2023 | -0.99% | Morgan Stanley | $45 → $46 | Maintains | Underweight | |||
08/03/2023 | 18.38% | Needham | $58 → $55 | Maintains | Buy | |||
07/13/2023 | 1.16% | Credit Suisse | $46 → $47 | Maintains | Neutral | |||
06/20/2023 | 1.16% | Stephens & Co. | → $47 | Reiterates | Equal-Weight → Equal-Weight | |||
05/09/2023 | -0.99% | Credit Suisse | $44 → $46 | Maintains | Neutral | |||
05/05/2023 | -3.14% | Morgan Stanley | $40 → $45 | Maintains | Underweight | |||
05/05/2023 | 24.84% | Needham | → $58 | Reiterates | → Buy | |||
02/23/2023 | -5.29% | Credit Suisse | $41 → $44 | Upgrade | Underperform → Neutral | |||
02/21/2023 | -3.14% | Stephens & Co. | → $45 | Reiterates | → Equal-Weight | |||
02/17/2023 | 24.84% | Needham | $54 → $58 | Maintains | Buy | |||
02/01/2023 | — | Northcoast Research | — | Downgrade | Buy → Neutral | |||
01/17/2023 | -13.9% | Morgan Stanley | $41 → $40 | Downgrade | Equal-Weight → Underweight | |||
12/13/2022 | -11.75% | Credit Suisse | → $41 | Initiates | → Underperform | |||
11/22/2022 | 7.62% | Cowen & Co. | $55 → $50 | Downgrade | Outperform → Market Perform | |||
11/07/2022 | 39.91% | Raymond James | $75 → $65 | Maintains | Strong Buy | |||
11/04/2022 | 16.23% | Needham | $52 → $54 | Maintains | Buy |
Cognexの最新目標株価Cognex。(NASDAQ:CGNX) の最新目標株価をTruist Securitiesが10 8, 2025日に発表した。このアナリスト会社はCognex ({{change}:{{mbol}}) {{{quoteName}}の{{change}:{{symbol}}からfallまで12ヶ月以内(-3.14% downsideの可能性あり)と予想する$45.00の目標株価を設定しました。過去1年間に34のアナリスト会社がレーティングを報告しています。
Cognexの最新のアナリストレーティングはCognexです。(NASDAQ:CGNX) の最新のアナリストレーティングはTruist Securitiesによるもので、CognexのCognexです。{actionCompany}}のhold評価です。
Cognex Corpの最後のアップグレードは8 1, 2025日に行われ、Keybancは目標株価を$50に引き上げました。companyName}}のKeybancの以前のa sector weightは$50でした。
Cognex Corpの最後の格下げは11 5, 2024日にTruist SecuritiesがCognex Corpの目標株価を$46から$43に変更した時です。
アナリストは、公開財務諸表を調べたり、Cognexの役員や顧客に話を聞いたり、決算の電話会議を傍聴したりと、広範な調査を行った上で株価の格付けを行っています。ほとんどのアナリストは3ヶ月ごとにこの作業を行いますので、毎年1社につき4つの格付けを得ることになります。companyName}}の最終レーティングは10 8, 2025日に提出されましたので、次のレーティングは10 8, 2026日あたりに提出されるものと思われます。
レーティングは主観的なものであり変化しますが、最新のCognex (CGNX) (CGNX) のレーティングは維持で、目標株価は$37.00から$45.00でした。現在の価格 Cognex ({{exchange}}) (CGNX) の現在の取引価格は$46.46で、これはアナリストの予測レンジout ofです。
ブラウズ アナリスト評価と目標株価 全銘柄の